PICO Portalanswers from OpenAlex & ORCID
Michael S. Gordon
ResearcherPublications, citations & collaboration network
Michael S. Gordon is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Michael S. Gordon have?
PICO Portalindexed works
Michael S. Gordon has 570 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael S. Gordon have?
PICO Portalcitation count
Michael S. Gordon has 28,331 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Michael S. Gordon?
PICO Portalh-index
Michael S. Gordon has an h-index of 73 in OpenAlex.
What is the i10-index of Michael S. Gordon?
PICO Portali10-index
Michael S. Gordon has an i10-index of 235 in OpenAlex.
What is the ORCID of Michael S. Gordon?
PICO Portalorcid
The ORCID for Michael S. Gordon is on the source record.
What is the OpenAlex record for Michael S. Gordon?
PICO Portalopenalex
The OpenAlex for Michael S. Gordon is on the source record.
What are the most-cited papers on Michael S. Gordon?
PICO Portalmost cited works
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
Jeffrey R. Infante, Leslie A. Fecher, Gerald S. Falchook, Sujatha Nallapareddy, Michael S. Gordon, Carlos Becerra, Douglas J. DeMarini, Donna S. Cox, Yanmei Xu, Shannon R. Morris, Vijay Peddareddigari, Ngocdiep T. Le, Lowell L. Hart, Johanna C. Bendell, Gail Eckhardt, Razelle Kurzrock, Keith T. Flaherty, Howard A. Burris, Wells A. Messersmith
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Gerald S. Falchook, Karl D. Lewis, Jeffrey R. Infante, Michael S. Gordon, Nicholas J. Vogelzang, Douglas J. DeMarini, Peng Sun, Christopher Moy, Stephen A. Szabo, Lori Roadcap, Vijay Peddareddigari, Peter F. Lebowitz, Ngocdiep T. Le, Howard A. Burris, Wells A. Messersmith, Peter J. O’Dwyer, Kevin B. Kim, Keith T. Flaherty, Johanna C. Bendell, René González, Razelle Kurzrock, Leslie A. Fecher
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.
Isidore Tepler, Laurence Elias, John W. Smith, Mohamad A. Hussein, Gerald Rosen, A. Y. Chang, Joseph O. Moore, Michael S. Gordon, Bernice Kuca, Kathleen J. Beach, John W. Loewy, Marc B. Garnick, James A. Kaye